Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Osteogenesis Imperfecta
Interventions
DRUG

Zoledronic Acid

Trial Locations (10)

19899

Alfred Dupont Hospital for Children, Wilmington

37232

Vanderbilt University Medical Center, Nashville

43205

Children's Hospital, Columbus

45229

Children's Hospital Medical Center, Cincinnati

68198

Children's Hospital, Omaha

77030

Texas Children's Hospital, Houston

83702

Intermountains Orthopedics, Boise

90095

UCLA Medical Center-Dept of Pediatric Nephrology, Los Angeles

97239

Oregon Health Sciences University, Portland

Unknown

For information regarding facilities, please contact the Central Contact, Multiple Locations

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY